Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway–tumour–stroma lung cancer model

Christophe Mas(Debiopharm (Switzerland)), Samuel Constant(Exelixis (United States)), Song Huang, Mireille Caul-Futy, Bernadett Boda(Exelixis (United States)), Ludovic Wiszniewski
Journal of Biotechnology
January 20, 2015
Cited by 24


Related Papers